# A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease

> **NCT01113593** · PHASE2 · COMPLETED · sponsor: **Dey** · enrollment: 45 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DRUG:** Formoterol Fumarate
- **DRUG:** Formoterol Fumarate
- **DRUG:** Formoterol Fumarate
- **DRUG:** Foradil Aerolizer
- **DRUG:** Foradil Aerolizer

## Key facts

- **NCT ID:** NCT01113593
- **Lead sponsor:** Dey
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-05
- **Final completion:** —
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2013-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01113593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01113593, "A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01113593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*